SYNTIMMUNE, INC.

Profile

Company Names

SYNTIMMUNE, INC.

Addresses

257 PARK AVENUE SOUTH, 15TH FLOOR, NEW YORK, NY 10010

Phone Numbers

212-498-0011 EXT 301

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$25,999,999.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2017-06-19 
$17,999,998.00 
$49,999,991.00 
$31,999,993.00 
Equity 
1
2014-10-17 
$8,000,001.00 
$26,000,002.00 
$18,000,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BURT 
 
ADELMAN, M.D. 
DIRECTOR
SYNTIMMUNE, INC.
LAURENCE 
 
BLUMBERG, M.D. 
EXECUTIVE OFFICER, DIRECTOR
SYNTIMMUNE, INC.
RICHARD 
 
BLUMBERG, M.D. 
DIRECTOR
SYNTIMMUNE, INC.
DAVID 
 
DE GRAAF, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
SYNTIMMUNE, INC.   |  COMET THERAPEUTICS, INC.
SAM 
 
HALL 
DIRECTOR
SYNTIMMUNE, INC.   |  CLASSPASS INC.   |  CHINOOK THERAPEUTICS U.S., INC.
SAM 
 
HALL, PH.D. 
DIRECTOR
SYNTIMMUNE, INC.
SETH 
 
HARRISON 
DIRECTOR
GLOUCESTER PHARMACEUTICALS INC   |  AILERON THERAPEUTICS INC   |  HEARTWARE INTERNATIONAL, INC.   |  APPLE TREE PARTNERS II - ANNEX, L.P.   |  SYNTIMMUNE, INC.   |  CURE FORWARD CORP.   |  TUSKER MEDICAL, INC.   |  GALA THERAPEUTICS, INC.   |  GALAXY MEDICAL, INC.   |  GALVANIZE THERAPEUTICS, INC.   |  GALAVANT THERAPEUTICS, INC.   |  OPAL BIOSCIENCES, INC.   |  NINE SQUARE THERAPEUTICS, INC.   |  APERTOR PHARMACEUTICALS, INC.   |  INITIAL THERAPEUTICS, INC.   |  NINE SQUARE THERAPEUTICS CORP   |  REPLICATE BIOSCIENCE, INC.   |  EVERCRISP BIOSCIENCES, INC.   |  RED QUEEN THERAPEUTICS, INC.   |  DEEP APPLE THERAPEUTICS, INC.   |  GALVANIZE THERAPEUTICS, INC.   |  MARLINSPIKE THERAPEUTICS, INC.   |  AETHON THERAPEUTICS, INC.   |  AULOS BIOSCIENCE, INC.
SETH 
 
HARRISON, M.D. 
DIRECTOR
SYNTIMMUNE, INC.
AARON 
 
KANTOFF 
DIRECTOR
CURE FORWARD CORP.   |  SYNTIMMUNE, INC.   |  CORVIDIA THERAPEUTICS, INC.   |  AKERO THERAPEUTICS, INC.   |  RAYZEBIO, INC.   |  CEPTUR THERAPEUTICS, INC.   |  PETRICHOR SCION THERAPEUTICS LLC   |  AVALO THERAPEUTICS, INC.
GEETA 
 
VEMURI 
DIRECTOR
ARGINETIX, INC.   |  CEMPRA HOLDINGS, LLC   |  CORRIDOR PHARMACEUTICALS, INC.   |  GLIKNIK INC   |  SYNTIMMUNE, INC.   |  ONCORESPONSE INC   |  AGENT CAPITAL FUND I LP   |  PYXIS ONCOLOGY, INC.   |  AGENT CAPITAL FUND II, LP   |  VITTORIA BIOTHERAPEUTICS, INC.   |  CARBON BIOSCIENCES, INC.   |  CANTAI THERAPEUTICS, INC.   |  AGENT CAPITAL FUND III LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-06-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-19 
2014-10-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#